Advertisement

Topics

Lycera Corporation Company Profile

19:35 EDT 24th March 2019 | BioPortfolio

Lycera Corp. is focused on the discovery and development of selective, small-molecule immunomodulators for the treatment of patients with autoimmune diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Lycera is developing drug candidates that target two novel therapeutic pathways and have the potential for first-in-class oral efficacy without the adverse effects of current standard-of-care antiproliferative and immunosuppressive agents. Lycera’s leading-edge technology platform and ATPase program are focused on the emerging area of cellular bioenergetics to selectively target and deplete pathologically activated cells. The company also has a lead program targeting the Th17 pathway through the inhibition of ROR-gamma. Lycera’s leadership team and advisors represent the core thought leaders in immunology, inflammation, organ transplantation and kinase biology and are responsible for key advances and discoveries in these fields. Founded in 2006, Lycera is headquartered in Cambridge, Mass. and has a state-of-the-art research center in Ann Arbor, Mich. Visit www.lycera.com for more information.


News Articles [111 Associated News Articles listed on BioPortfolio]

Orion Corporation: Managers' transactions - Olli Huotari

ORION CORPORATION         MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Olli Huotari Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Christer Nordstedt

 ORION CORPORATION        MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Christer Nordstedt Orion Corporation has receiv...

Orion Corporation: Managers' transactions - Satu Ahomäki

ORION CORPORATION     MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Satu Ahomäki   Orion Corporation has received the fo...

Orion Corporation: Managers' transactions - Virve Laitinen

ORION CORPORATION      MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Virve Laitinen Orion Corporation has received the f...

Orion Corporation: Managers' transactions - Timo Lappalainen

ORION CORPORATION     MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Timo Lappalainen Orion Corporation has received...

Orion Corporation: Managers' transactions - Jari Karlson

ORION CORPORATION      MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Jari Karlson Orion Corporation has received the fol...

Orion Corporation: Managers' transactions - Markku Huhta-Koivisto

ORION CORPORATION         MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Markku Huhta-Koivisto Orion Corporation has rec...

Paul Sekhri Joins eGenesis as President & CEO

Biotech company eGenesis has appointed Paul Sekhri to serve as president and CEO, a position he held at his previous company, Lycera. Sekhri’s experience also includes posts at Teva Pharmaceutical I...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [182 Associated Companies listed on BioPortfolio]

Lycera Corp.

Lycera Corp. is focused on the discovery and development of small-molecule immunomodulators for the treatment of immunologic diseases, including psoriasis, rheumatoid arthritis, lupus erythematosis, i...

Lycera Corporation

Lycera Corp. is focused on the discovery and development of selective, small-molecule immunomodulators for the treatment of patients with autoimmune diseases such as rheumatoid ar...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Protective Life Corporation

Protective Life Corporation provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. The compan...

More Information about "Lycera Corporation" on BioPortfolio

We have published hundreds of Lycera Corporation news stories on BioPortfolio along with dozens of Lycera Corporation Clinical Trials and PubMed Articles about Lycera Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lycera Corporation Companies in our database. You can also find out about relevant Lycera Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...


Corporate Database Quicklinks



Searches Linking to this Company Record